Temozolomide for treating brain metastasesABREY, Lauren E; CHRISTODOULOU, Christos.Seminars in oncology. 2001, Vol 28, Num 4, pp 34-42, issn 0093-7754, SUP13Article

Treatment-related neurotoxicityABREY, Lauren E; CORREA, Denise D.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vii, 729-738 [11 p.]Article

Central nervous system lymphomasDEANGELIS, Lisa M; ABREY, Lauren E.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, 185 p.Serial Issue

Intracranial Dural MetastasesNAYAK, Lakshmi; ABREY, Lauren E; IWAMOTO, Fabio M et al.Cancer. 2009, Vol 115, Num 9, pp 1947-1953, issn 0008-543X, 7 p.Article

Brain metastases : Old problem, new strategiesNGUYEN, Teri D; ABREY, Lauren E.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vii-viii, 369-388 [22 p.]Article

Unusual variants of primary central nervous system lymphomaSHENKIER, Tamara N.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vi, 651-664 [15 p.]Article

Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomasMORRIS, Patrick G; ABREY, Lauren E.Targeted oncology. 2010, Vol 5, Num 3, pp 193-200, issn 1776-2596, 8 p.Article

Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphomaBIERMAN, Philip; GIGLIO, Pierre.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, v, 597-609 [14 p.]Article

Primary dural lymphomas : A clinicopathologic study of treatment and outcome in eight patientsIWAMOTO, Fabio M; DEANGELIS, Lisa M; ABREY, Lauren E et al.Neurology. 2006, Vol 66, Num 11, pp 1763-1765, issn 0028-3878, 3 p.Article

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphomaGAVRILOVIC, Igor T; HORMIGO, Adilia; YAHALOM, Joachim et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4570-4574, issn 0732-183X, 5 p.Article

Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-upOMURO, Antonio M. P; DEANGELIS, Lisa M; YAHALOM, Joachim et al.Neurology. 2005, Vol 64, Num 1, pp 69-74, issn 0028-3878, 6 p.Article

Leukemic and lymphomatous meningitis : incidence, prognosis and treatmentCHAMBERLAIN, Marc C; NOLAN, Craig; ABREY, Lauren E et al.Journal of neuro-oncology. 2005, Vol 75, Num 1, pp 71-83, issn 0167-594X, 13 p.Article

Treatment of primary central nervous system lymphomaSHAH, Gaurav D; DEANGELIS, Lisa M.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, v, 611-627 [18 p.]Article

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinomaLAI, Rose; DANG, Chau T; MALKIN, Mark G et al.Cancer. 2004, Vol 101, Num 4, pp 810-816, issn 0008-543X, 7 p.Article

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphomaHOTTINGER, Andreas F; DEANGELIS, Lisa M; YAHALOM, Joachim et al.Neurology. 2007, Vol 69, Num 11, pp 1178-1182, issn 0028-3878, 5 p.Article

Clinical features and diagnosis of primary central nervous system lymphomaFITZSIMMONS, April; UPCHURCH, Kristen; BATCHELOR, Tracy et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vii, 689-703 [16 p.]Article

New treatment approaches in primary central nervous system lymphomaSOUSSAIN, Carole; KHE, Hoang-Xuan; DOOLITTLE, Nancy D et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vii, 719-728 [11 p.]Article

Bcl-6 Predicts Improved Prognosis in Primary Central Nervous System LymphomaLEVY, Oren; DEANGELIS, Lisa M; FILIPPA, Daniel A et al.Cancer. 2008, Vol 112, Num 1, pp 151-156, issn 0008-543X, 6 p.Article

Chemotherapy and the treatment of brain metastasesPEAK, Scott; ABREY, Lauren E.Hematology/oncology clinics of North America. 2006, Vol 20, Num 6, issn 0889-8588, viii-ix, 1287-1295 [10 p.]Article

Prognostic factors in primary central nervous system lymphomasFERRERI, Andrés J. M; RENI, Michele.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vi, 629-649 [22 p.]Article

AIDS-related primary central nervous system lymphomaKASAMON, Yvette L; AMBINDER, Richard F.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, pp vi-vii, issn 0889-8588, 24 p.Article

Pathology and genetics of primary central nervous system and intraocular lymphomaRUBENSTEIN, James L; TRESELER, Patrick; O'BRIEN, Joan M et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vii, 705-717 [14 p.]Article

Secondary central nervous system lymphoma : Risk factors and prophylaxisMONTOTO, Silvia; LISTER, T. Andrew.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, viii, 751-763 [14 p.]Article

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?KHAN, Raja B; SHI, Weiji; THALER, Howard T et al.Journal of neuro-oncology. 2002, Vol 58, Num 2, pp 175-178, issn 0167-594XArticle

Retinopathy in survivors of primary central nervous system lymphomaGRIMM, Sean A; YAHALOM, Joachim; ABREY, Lauren E et al.Neurology. 2006, Vol 67, Num 11, pp 2060-2062, issn 0028-3878, 3 p.Article